A clinical trial of the bronchodilator effect of Sch 1000 aerosol in asthmatic children.
In a double-blind study in 23 asthmatic patients Sch 1000 was found to be an effective bronchodilator with an onset of effect within 15 minutes and a duration of four hours. It was effective on both small and large airways.
D000293:Adolescent; D000328:Adult; D000336:Aerosols; D000402:Airway Obstruction / Q000188:drug therapy; D001249:Asthma / Q000188:drug therapy*; D001285:Atropine / Q000627:therapeutic use*; D001993:Bronchodilator Agents / Q000627:therapeutic use*; D002648:Child; D002986:Clinical Trials as Topic; D004311:Double-Blind Method; D005260:Female; D005541:Forced Expiratory Volume; D006801:Humans; D008297:Male; D009921:Metaproterenol / Q000494:pharmacology; D010366:Peak Expiratory Flow Rate
D000336:Aerosols; D001993:Bronchodilator Agents; D009921:Metaproterenol; D001285:Atropine